244 related articles for article (PubMed ID: 19020388)
21. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
Losa M; Gatti E; Rossini A; Lanzi R
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
[TBL] [Abstract][Full Text] [Related]
22. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL
Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824
[TBL] [Abstract][Full Text] [Related]
23. Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.
Child CJ; Conroy D; Zimmermann AG; Woodmansee WW; Erfurth EM; Robison LL
Eur J Endocrinol; 2015 Jun; 172(6):779-90. PubMed ID: 25810462
[TBL] [Abstract][Full Text] [Related]
24. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R
Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238
[TBL] [Abstract][Full Text] [Related]
25. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
26. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
27. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
28. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
29. Chronic hypopituitarism after traumatic brain injury: risk assessment and relationship to outcome.
Bavisetty S; Bavisetty S; McArthur DL; Dusick JR; Wang C; Cohan P; Boscardin WJ; Swerdloff R; Levin H; Chang DJ; Muizelaar JP; Kelly DF
Neurosurgery; 2008 May; 62(5):1080-93; discussion 1093-4. PubMed ID: 18580806
[TBL] [Abstract][Full Text] [Related]
30. Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.
Holmer H; Svensson J; Rylander L; Johannsson G; Rosén T; Bengtsson BA; Thorén M; Höybye C; Degerblad M; Bramnert M; Hägg E; Edén Engström B; Ekman B; Norrving B; Hagmar L; Erfurth EM
J Clin Endocrinol Metab; 2007 Sep; 92(9):3560-7. PubMed ID: 17623762
[TBL] [Abstract][Full Text] [Related]
31. Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database.
Maiter D; Abs R; Johannsson G; Scanlon M; Jönsson PJ; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Aug; 155(2):253-60. PubMed ID: 16868138
[TBL] [Abstract][Full Text] [Related]
32. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
Holmer H; Ekman B; Björk J; Nordstöm CH; Popovic V; Siversson A; Erfurth EM
Eur J Endocrinol; 2009 Nov; 161(5):671-9. PubMed ID: 19667040
[TBL] [Abstract][Full Text] [Related]
33. Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study.
Lamberts SW
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):2-5. PubMed ID: 19020377
[TBL] [Abstract][Full Text] [Related]
34. The effect of growth hormone on pituitary tumour growth.
Herring R; Russell-Jones D
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595
[TBL] [Abstract][Full Text] [Related]
35. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.
Heinks K; Boekhoff S; Hoffmann A; Warmuth-Metz M; Eveslage M; Peng J; Calaminus G; Müller HL
Endocrine; 2018 Feb; 59(2):364-372. PubMed ID: 29230635
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of growth hormone replacement therapy in adults.
Toogood A
Expert Opin Drug Saf; 2005 Nov; 4(6):1069-82. PubMed ID: 16255665
[TBL] [Abstract][Full Text] [Related]
37. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181
[TBL] [Abstract][Full Text] [Related]
38. HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA.
Wolf P; Winhofer Y; Smajis S; Kruschitz R; Schindler K; Gessl A; Riedl M; Vila G; Raber W; Langer F; Prager G; Ludvik B; Luger A; Krebs M
Endocr Pract; 2016 May; 22(5):595-601. PubMed ID: 26789341
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis.
Attanasio AF; Jung H; Mo D; Chanson P; Bouillon R; Ho KK; Lamberts SW; Clemmons DR;
J Clin Endocrinol Metab; 2011 Jul; 96(7):2255-61. PubMed ID: 21543424
[TBL] [Abstract][Full Text] [Related]
40. [Pathological daytime sleepiness in an 11-year old girl receiving growth hormone treatment previously cured from craniopharyngioma].
Korpal-Szczyrska M; Birkholz D; Okońska M; Pawłowicz M; Szczyrski J
Pediatr Endocrinol Diabetes Metab; 2012; 18(4):158-62. PubMed ID: 23739621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
